You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy

Authors

  • Xiaoyu Jiang Vanderbilt University Institute of Imaging Science, Nashville, TN 37232, United States Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • Stephanie Dudzinski Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, United States Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • Kathryn E Beckermann Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • Kirsten Young Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • Eliot McKinley Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • J Oliver McIntyre Vanderbilt University Institute of Imaging Science, Nashville, TN 37232, United States Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, United States Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, United States Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • Jeffrey C Rathmell Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, United States Vanderbilt Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • Junzhong Xu Vanderbilt University Institute of Imaging Science, Nashville, TN 37232, United States Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, United States Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, United States Department of Physics and Astronomy, Vanderbilt University, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  • John C Gore Vanderbilt University Institute of Imaging Science, Nashville, TN 37232, United States Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, United States Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, United States Department of Physics and Astronomy, Vanderbilt University, Nashville, TN 37232, United States PubMed articlesGoogle scholar articles
  1. Correspondence to Dr John C Gore; john.gore{at}vumc.org
View Full Text

Citation

Jiang X, Dudzinski S, Beckermann KE, et al
MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy
Journal for ImmunoTherapy of Cancer 2020;8:e000328. doi: 10.1136/jitc-2019-000328

Publication history

  • Accepted May 16, 2020
  • First published June 23, 2020.
Online issue publication 
June 23, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.